Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

DENTSPLY SIRONA (NASDAQ: XRAY): Progress on the Return-to-Growth Action Plan

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is one of the world's largest manufacturers of professional dental products and technologies, spanning imaging systems, CAD/CAM equipment, orthodontic clear aligners, implants, endodontic tools and consumables. On August 6, 2026, the company reported second-quarter 2026 results that captured its …

Nitish Kishor | 10 September 2026

Premier Biomedical (OTC: BIEI): The Pivot From Biomedical Research to Graphene Defense

Premier Biomedical, Inc. (OTC: BIEI) historically described itself as a research-based company developing products for conditions such as PTSD, cancer and pain, including hemp-oil-based topical products. Over the past two years it has shifted its focus toward graphene technology and applications, branding that effort …

Nitish Kishor | 10 September 2026

ASP Isotopes (NASDAQ: ASPI): The Long-Range Plan Unveiled at Capital Markets Day

ASP Isotopes Inc. (NASDAQ: ASPI) is an advanced-materials company that enriches and produces isotopes for nuclear medicine, semiconductors and energy, and it has expanded through Renergen's helium andLNGoperations in South Africa and its Quantum Leap Energy nuclear-fuel subsidiary. On September 8, 2026, ASP Isotopes …

Nitish Kishor | 10 September 2026

Encision (OTC: ECIA): What Deregistration Means for the Surgical-Device Maker

Encision Inc. (OTC: ECIA) is a Colorado-based medical-device company known for its Active Electrode Monitoring (AEM) technology, which is designed to prevent stray electrosurgical burns during minimally invasive laparoscopic surgery. In a defining move, Encision's board approved filing a Form 15 to voluntarily deregister …

Nitish Kishor | 10 September 2026

ANI Pharmaceuticals (NASDAQ: ANIP): Cortrophin Gel Drives Record Quarterly Growth

ANI Pharmaceuticals is a diversified drugmaker headquartered in Princeton, New Jersey, operating across three segments: rare disease, generics and established brands. Its flagship product is Cortrophin Gel (repository corticotropin injection), a purified adrenocorticotropic hormone therapy used in conditions spanning rheumatology, neurology and ophthalmology. On …

Nitish Kishor | 10 September 2026

Avoca (AVOA): Why the Ticker's Identity and Listing Status Need Verifying

Efforts to confirm a listed operating company behind the AVOA ticker were inconclusive. Standard market-data pages for AVOA, as either a common stock or an exchange-traded fund, were not available, and a full-text search of U.S. Securities and Exchange Commission filings returned no operating …

Nitish Kishor | 10 September 2026

Tenaya Therapeutics (NASDAQ: TNYA): Gene Therapy Data for Inherited Heart Disease

Tenaya Therapeutics is a South San Francisco-based clinical-stage biotechnology company developing therapies for genetic and other forms of heart disease. Its lead gene-therapy programs are TN-201, aimed at MYBPC3-associated hypertrophic cardiomyopathy, and TN-401, targeting PKP2-associated arrhythmogenic right ventricular cardiomyopathy. On August 5, 2026, Tenaya …

Nitish Kishor | 10 September 2026

Stryker Corporation (NYSE: SYK): Robotics and Implants Anchor a Medtech Giant

Stryker (SEC CIK 310764) is a diversifiedMedTechgiant organized around two broad segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its portfolio spans surgical instruments, hospital equipment, neurovascular devices, trauma and joint-replacement implants, and - most visibly - the Mako robotic-arm platform used in orthopedic …

Nitish Kishor | 10 September 2026

Nutriband (NASDAQ: NTRB): The AVERSA Abuse-Deterrent Patch Platform

Nutriband (SEC CIK 1676047) is a pharmaceutical company focused on transdermal and topical products. Its centerpiece is the AVERSA abuse-deterrent transdermal technology, designed to be incorporated into patches - most prominently an abuse-deterrent fentanyl patch - to help deter misuse, diversion and accidental exposure. …

Nitish Kishor | 10 September 2026

PharmaCyte Biotech (NASDAQ: PMCB): The Gap Between Market Value and Cash Position

Headquartered in Las Vegas, Nevada, PharmaCyte Biotech built its early identity around "Cell-in-a-Box," a live-cell encapsulation technology once positioned for pancreatic cancer and other indications. In recent years the company has shifted decisively away from clinical spending and toward what it frames as tactical …

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…